Replies to post #767021 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Sharpie, You are absolutely right on all those points. Post-approval, the demand for DCVax-L will likely immediately and easily overwhelm the supply in the beginning. That puts pressure on regulatory agencies to fast track the approval of Flaskworks. And the other side of that coin is, that type of major demand > supply will also drive the stock price up, and align perfectly for financing needs to fund the Flaskworks buildout.

[sharpie510]

In addition to mesenchymal, MGMT methylated would be up there.
🙏🙏🙏🙏🙏🙏
But what if $NWBO will be ready to roll out Flaskworks at the time patients need it? Then all bets are off!
💪💪💪💪💪💪#FreezeYourTumor #GetDCVax#dcvax #glioblastoma #gbmhttps://t.co/sawNC978TN

— rj (@sharpie510) May 11, 2025